Aberrant methylation of CDH11 predicts a poor outcome for patients with bladder cancer.
about
Cadherin-11 Is a Cell Surface Marker Up-Regulated in Activated Pancreatic Stellate Cells and Is Involved in Pancreatic Cancer Cell Migration.Genome-wide measures of DNA methylation in peripheral blood and the risk of urothelial cell carcinoma: a prospective nested case-control study.Epigenetic inactivation of tumour suppressor coding and non-coding genes in human cancer: an update.MicroRNA-335-5p is a potential suppressor of metastasis and invasion in gastric cancer.MGMT promoter methylation as a potential prognostic marker for acute leukemia.
P2860
Aberrant methylation of CDH11 predicts a poor outcome for patients with bladder cancer.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Aberrant methylation of CDH11 predicts a poor outcome for patients with bladder cancer.
@en
Aberrant methylation of CDH11 predicts a poor outcome for patients with bladder cancer.
@nl
type
label
Aberrant methylation of CDH11 predicts a poor outcome for patients with bladder cancer.
@en
Aberrant methylation of CDH11 predicts a poor outcome for patients with bladder cancer.
@nl
prefLabel
Aberrant methylation of CDH11 predicts a poor outcome for patients with bladder cancer.
@en
Aberrant methylation of CDH11 predicts a poor outcome for patients with bladder cancer.
@nl
P2093
P2860
P356
P1433
P1476
Aberrant methylation of CDH11 predicts a poor outcome for patients with bladder cancer.
@en
P2093
Jian-Guo Ma
Shi-Liang Gui
Ying-Li Lin
P2860
P304
P356
10.3892/OL.2015.3337
P577
2015-06-08T00:00:00Z